Not Signed In -
24 Hour Fitness |
|
|
24 Hour Fitness is a United States-based chain of privately owned and operated fitness centers, founded in 1983. There are many 24 Hour Fitness clubs in 16 U.S. states as well as in Hong Kong, Malaysia, Singapore, and Taiwan. ...
Wikipedia - [full article]
24 Hour Fitness Clinical Trials
- 24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
ClinicalTrials.gov Identifier: NCT00154570 - Recruiting
Reflux Esophagitis
- Methylprednisolone Given by 24-Hour or 48-Hour Infusion versus Tirilazad for Acute Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00004759 - Active, not recruiting
Spinal Cord Injury
- Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
ClinicalTrials.gov Identifier: NCT00436592 - Recruiting
Cerebrovascular Accident
- Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
ClinicalTrials.gov Identifier: NCT00474058 - Recruiting
Parkinson Disease
- 24-Hour IOP Control With the Bimatoprost/Timolol Fixed Combination
ClinicalTrials.gov Identifier: NCT00486486 - Recruiting
Exfoliative Glaucoma
- 24-Hour IOP & Blood Pressure Control in POAG & OHT Patients
ClinicalTrials.gov Identifier: NCT00330577 - Active, not recruiting
Primary Open Angle Glaucoma; Ocular Hypertension
- 24-Hour IOP-Lowering Effect of Brimonidine 0.1%
ClinicalTrials.gov Identifier: NCT00457795 - Recruiting
Open-Angle Glaucoma; Ocular Hypertension
- Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00533858 - Recruiting
Hypertension
- Single Ascending Dose of GAP-134 as a 24-Hour IV Infusion in Healthy Japanese Males
ClinicalTrials.gov Identifier: NCT00543946 - Recruiting
Arrhythmia
- An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00442208 - Active, not recruiting
Healthy
- 24-Hour NAVA Ventilation in Acute Respiratory Failure
ClinicalTrials.gov Identifier: NCT00583037 - Recruiting
Respiration, Artificial; Respiratory Insufficiency
- Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of QMF Twisthaler (Indacaterol Maleate/Mometasone Furoate)
ClinicalTrials.gov Identifier: NCT00557440 - Recruiting
Asthma
- Fitness Training in Children
ClinicalTrials.gov Identifier: NCT00205296 - Active, not recruiting
Obesity; Low Fitness
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00516074 - Recruiting
Type 2 Diabetes Mellitus
- Bi-Weekly Docetaxel Plus 24-Hour Infusion of HDFL and for Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00155883 - Recruiting
Gastric Cancer
- Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients with Solid Malignancies.
ClinicalTrials.gov Identifier: NCT00162136 - Recruiting
Solid Malignancies
- Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)
ClinicalTrials.gov Identifier: NCT00108225 - Recruiting
Diabetes Mellitus, Type 2
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
Hepatitis C, Chronic
- Neuromuscular and Cognitive Fatigue During a 24 Hour Treadmill Running Exercise
ClinicalTrials.gov Identifier: NCT00428779 - Completed
Healthy
- 24-Hour IOP Control With TTFC vs Travoprost When Both Are Given PM in Subjects With POAG
ClinicalTrials.gov Identifier: NCT00444184 - Completed
Glaucoma
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
ClinicalTrials.gov Identifier: NCT00551538 - Completed
Type 2 Diabetes
- 24-Hour IOP Control With Travoprost/Timolol Fixed Combination
ClinicalTrials.gov Identifier: NCT00331240 - Completed
Primary Open Angle Glaucoma; Exfoliation Syndrome
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
ClinicalTrials.gov Identifier: NCT00410592 - Completed
Gastroesophageal Reflux Disease
- Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
ClinicalTrials.gov Identifier: NCT00050401 - Completed
Pneumonia
- Efficacy and Safety (Including 24-Hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD
ClinicalTrials.gov Identifier: NCT00239460 - Completed
Pulmonary Disease, Chronic Obstructive
- 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00318656 - Completed
Non-Insulin-Dependent Diabetes Mellitus
- Life 2: Improving Fitness and Function in Elders
ClinicalTrials.gov Identifier: NCT00435188 - Active, not recruiting
Aging; Disability; Mobility Limitations
- Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
ClinicalTrials.gov Identifier: NCT00185991 - Active, not recruiting
Chorioamnionitis
- Safety Assessment of One-Hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00292864 - Active, not recruiting
Tumors
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00241423 - Completed
Type 2 Diabetes Mellitus
- Study of 24-Hour Intragastric pH Profiles of Esomeprazole 40 Mg and Lansoprazole 30 Mg in Healthy Volunteer Subjects
ClinicalTrials.gov Identifier: NCT00230516 - Completed
Healthy
- One Hour Preoperative Gatifloxacin
ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
Ophthalmic Surgery
- Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance
ClinicalTrials.gov Identifier: NCT00139984 - Completed
Hypertension
- Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics
ClinicalTrials.gov Identifier: NCT00527462 - Recruiting
Asthma
- Myogenic and Osteogenic Responses to eXercise and Ibuprofen
ClinicalTrials.gov Identifier: NCT00462722 - Recruiting
Aging; Physical Fitness
- A Sub-Study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin
ClinicalTrials.gov Identifier: NCT00468039 - Active, not recruiting
Diabetes Mellitus, Type 2
- A 24-52-Week Study to Evaluate the Long-Term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)
ClinicalTrials.gov Identifier: NCT00336713 - Active, not recruiting
Depressive Disorder
- 24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma
ClinicalTrials.gov Identifier: NCT00397241 - Completed
Open-Angle Glaucoma
- A 24-Week up-Titration Trial of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360555 - Active, not recruiting
Sexual Dysfunctions, Psychological
- Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-Hour Application
ClinicalTrials.gov Identifier: NCT00466570 - Recruiting
Conjunctical Flora
- 24-Week Placebo-Controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360529 - Active, not recruiting
Sexual Dysfunctions, Psychological
- A 24-Week Fixed Dose Trial of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360243 - Active, not recruiting
Sexual Dysfunctions, Psychological
- Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.
ClinicalTrials.gov Identifier: NCT00430456 - Recruiting
Stroke
- A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease
ClinicalTrials.gov Identifier: NCT00283933 - Active, not recruiting
Fabry Disease
- Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
ClinicalTrials.gov Identifier: NCT00449046 - Active, not recruiting
Bronchial Asthma
- Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACWY at 24 to 30 m in Primed Subjects
ClinicalTrials.gov Identifier: NCT00317109 - Active, not recruiting
Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
Hypertension; Diabetic Nephropathy
- Influence of Fitness on Brain and Cognition
ClinicalTrials.gov Identifier: NCT00438347 - Recruiting
Aging; Cognition
- Tai Chi or Aerobic Exercise in Improving Physical Fitness and Lowering Stress in Cancer Survivors
ClinicalTrials.gov Identifier: NCT00414791 - Recruiting
Psychosocial Effects/Treatment; Unspecified Adult Solid Tumor, Protocol Specific
- Preventing Osteoporosis in Adolescent Girls
ClinicalTrials.gov Identifier: NCT00069173 - Recruiting
Osteoporosis
- Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors
ClinicalTrials.gov Identifier: NCT00246818 - Recruiting
Cancer; Cancer Survivor
- Study of Hand Therapy 3 to 24 Months After Stroke
ClinicalTrials.gov Identifier: NCT00435617 - Recruiting
Cerebrovascular Accident
- Betamethasone Dosing Interval - 12 or 24 Hours?
ClinicalTrials.gov Identifier: NCT00453141 - Recruiting
Preterm Delivery
- HYPGENE-Genetics Fitness Obesity & Risk of Hypertension
ClinicalTrials.gov Identifier: NCT00083811 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Hypertension; Obesity
- Exercise and Physical Fitness for Persons With Knee Osteoarthritis
ClinicalTrials.gov Identifier: NCT00265447 - Recruiting
Knee Osteoarthritis
- Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours
ClinicalTrials.gov Identifier: NCT00108017 - Active, not recruiting
Glaucoma; Ocular Hypertension
- Cardiovascular Fitness for Robotically Assisted Treadmill Training in Persons With Chronic Incomplete Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00385918 - Recruiting
Spinal Cord Injury; Tetraplegia; Quadriplegia; Paraplegia
- Aerobic Exercise Training & the Autonomic System In Patients After Myocardial Infarction or Stroke
ClinicalTrials.gov Identifier: NCT00259948 - Not yet recruiting
HR Vaiability, Aerobic Physical Fitness,Blood Pressure, Blood Sugar Level, Blood HDL, LDL
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
ClinicalTrials.gov Identifier: NCT00495131 - Recruiting
Chronic Hepatitis C
- 20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA
ClinicalTrials.gov Identifier: NCT00106457 - Active, not recruiting
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Metabolic Syndrome X; Hypertension; Obesity
- EARLY 3-Months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
ClinicalTrials.gov Identifier: NCT00562588 - Recruiting
Cerebrovascular Accident
- Treatment of Children Less Than 24 Months of Age With Confirmed Influenza With Oseltamivir
ClinicalTrials.gov Identifier: NCT00391768 - Recruiting
Influenza
- Study of Loestrin 24 Fe vs. Loestrin 1/20
ClinicalTrials.gov Identifier: NCT00475189 - Recruiting
Pelvic Pain; Headaches; Emotional
- Needle-Free Jet Injection of Reduced-Dose, Intradermal, Influenza Vaccine in >= 6 to < 24-Month-Old Children
ClinicalTrials.gov Identifier: NCT00386542 - Recruiting
Influenza
- Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
ClinicalTrials.gov Identifier: NCT00423800 - Recruiting
Hepatitis C, Chronic
- Continuous Positive Airway Pressure (CPAP) Versus Surfactant, and a Lower Versus a Higher Oxygen Saturation in 24 to 27 Week Preterm Infants
ClinicalTrials.gov Identifier: NCT00233324 - Recruiting
Bronchopulmonary Dysplasia; Retinopathy of Prematurity
- 24 Months of Exemestane or Letrozole to Treat Breast Cancer
ClinicalTrials.gov Identifier: NCT00263913 - Recruiting
Breast Cancer
- Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
ClinicalTrials.gov Identifier: NCT00493285 - Recruiting
Respirovirus Infections; Respiratory Syncytial Virus Infections; Parainfluenza Virus 3, Human
- Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)
ClinicalTrials.gov Identifier: NCT00419705 - Recruiting
Ischemic Stroke
- Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy with Peginterferon and Ribavirin for HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00143000 - Recruiting
Hepatitis C Virus
- PEPAF: Evaluation of Family Physician''s Effectiveness for Physical Activity Promotion
ClinicalTrials.gov Identifier: NCT00131079 - Completed
Exercise; Physical Fitness; Quality of Life
- A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients with Fanconi Anemia.
ClinicalTrials.gov Identifier: NCT00058565 - Recruiting
Fanconi's Anemia
- 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
ClinicalTrials.gov Identifier: NCT00555789 - Recruiting
Kidney Transplantation
- Internet-Based Individualized Health Behavior Program or Internet-Based Standard Health Behavior Program in Preventing Cancer and Improving Physical Activity, Fitness, and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index
ClinicalTrials.gov Identifier: NCT00128570 - Recruiting
unspecified adult solid tumor, protocol specific
- A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection
ClinicalTrials.gov Identifier: NCT00000760 - Completed
HIV Infections
- Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
ClinicalTrials.gov Identifier: NCT00545675 - Not yet recruiting
Bipolar Disorder
- Impact of Polymorphisms of OAT1, OAT3 and OCT2 on Transportation of Potential Nephrotoxic Drugs
ClinicalTrials.gov Identifier: NCT00251017 - Not yet recruiting
Subjects 16 Years of Age or Older, of Either Sex.; Subjects Have a Medication Including Vancomycin
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00001669 - Completed
Multiple Sclerosis
- Fitness Training After Traumatic Brain Injury
ClinicalTrials.gov Identifier: NCT00251108 - Completed
Craniocerebral Trauma
- A Study of Ro 24-7429 in Patients with HIV-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00002314 - Completed
Sarcoma, Kaposi; HIV Infections
- Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-Hour IV of MOA-728 in Stable Methadone Subjects
ClinicalTrials.gov Identifier: NCT00444158 - Completed
Constipation
- Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients with Refractory Malignancy
ClinicalTrials.gov Identifier: NCT00001387 - Completed
Neoplasms
- Fitness and Exercise for People With Arthritis
ClinicalTrials.gov Identifier: NCT00252070 - Completed
Arthritis
- An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial
ClinicalTrials.gov Identifier: NCT00218881 - Completed
HIV Counseling and Testing; HIV Infections
- Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.
ClinicalTrials.gov Identifier: NCT00521170 - Completed
Allergy
- Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC 630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients with Refractory Neoplasms
ClinicalTrials.gov Identifier: NCT00001578 - Completed
Neoplasm
- 14 Vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response
ClinicalTrials.gov Identifier: NCT00308048 - Completed
Hepatitis C Virus Infection
- Fitness and Daily Function in Adults
ClinicalTrials.gov Identifier: NCT00018265 - Completed
Cardiovascular Disease
- A PK Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age
ClinicalTrials.gov Identifier: NCT00410709 - Completed
Pediculosis Capitis (Head Lice)
- A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination with Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00001428 - Completed
Colorectal Neoplasms
- A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin with G-CSF Support in Patients with Advanced Ovarian Cancer Previously Treated with Paclitaxel and Cisplatin
ClinicalTrials.gov Identifier: NCT00001427 - Completed
Ovarian Neoplasms
- Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics
ClinicalTrials.gov Identifier: NCT00255957 - Completed
Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
- Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
ClinicalTrials.gov Identifier: NCT00443482 - Completed
Asthma
- Immunogenicity & Safety Study to Evaluate the Response to a Booster Dose of GSK Biologicals'' Tritanrix™-HepB/Hib-MenAC Vaccine at 15-24 Months and to Evaluate the Response to Mencevax™ ACWY at 24-30 Months in Healthy Children Primed with
ClinicalTrials.gov Identifier: NCT00136604 - Completed
Prophylaxis diphtheria, tetanus, pertussis, hepatits B, Haemophilus influenzae type b and meningococcal serogroup A & C disease
- A Study of the Effects of Advantage 24 on the Rectum
ClinicalTrials.gov Identifier: NCT00000929 - Completed
HIV Infections
- Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients with Stage III/IV and Relapsed NSCLC
ClinicalTrials.gov Identifier: NCT00001450 - Completed
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms
- Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease
ClinicalTrials.gov Identifier: NCT00298129 - Completed
Diabetes Mellitus; Essential Hypertension; Renal Failure; Chronic Nephropathy
- Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction
ClinicalTrials.gov Identifier: NCT00106236 - Completed
Diabetes Mellitus; Hypertension; Hyperlipidemia
- Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients with AIDS or Advanced ARC who Cannot be Maintained on Zidovudine ( AZT ) Therapy.
ClinicalTrials.gov Identifier: NCT00002256 - Completed
HIV Infections
Resources
- 24 Hour Fitness Centers: The truth about the health club. (Chase Freedom)
email this page
print this page
bookmark this page
feedback on this page
